ExploreWatchlistsPricing
  1. JP-listed companies
  2. TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
  3. Financials
  4. Operating expenses

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. (E25678)

Market cap
P/E ratio
Taisho Pharmaceutical Holdings develops and sells both over-the-counter and prescription medicines, along with health products, serving customers in Japan and internationally.
SummaryFinancialsDividendsHistoryWorkforce
Period EndOperating expenses (Million JPY)YoY (%)
Mar 31, 2023154,831+1.14%
Mar 31, 2022153,088-1.88%
Mar 31, 2021156,021-1.83%
Mar 31, 2020158,923+14.37%
Mar 31, 2019138,951-4.83%
Mar 31, 2018146,007-0.17%
Mar 31, 2017146,260-1.13%
Mar 31, 2016147,935+1.14%
Mar 31, 2015146,273+2.28%
Mar 31, 2014143,009+1.52%
Mar 31, 2013140,873

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat